Steatosis Is an Independent Predictor of Relapse Following Rapid Virologic Response in Patients With HCV Genotype 3

BACKGROUND & AIMS: It is recommended that patients with chronic hepatitis C virus (HCV) genotype 3 infections receive 24 weeks of treatment. A rapid virologic response (RVR, at week 4) predicts a sustained virologic response (SVR), although not all patients with an RVR achieve an SVR. We explore...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SHAH, SAMIR R., PATEL, KEYUR, MARCELLIN, PATRICK, FOSTER, GRAHAM R., MANNS, MICHAEL, KOTTILIL, SHYAM, HEALEY, LETHA, PULKSTENIS, ERIK, SUBRAMANIAN, G. MANI, MCHUTCHISON, JOHN G., SULKOWSKI, MARK S., ZEUZEM, STEFAN, NELSON, DAVID R.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2011
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3155986/
https://ncbi.nlm.nih.gov/pubmed/21640198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2011.04.029
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge